Results 51 to 60 of about 2,402,468 (250)

A qualitative exploration of the potential role of using online social media support communities to increase initiation of Medications for Opioid Use Disorder (MOUD)

Journal of Substance Use, 2023
This study sought to explore the potential role of peer-led online communities to increase use of medications for opioid use disorder.From January through March 2020, participants with opioid use disorder and their family members/friends were recruited from paid Facebook ads; public health key stakeholders were recruited from referrals from the study ...
Renee Garett, William G. Cumberland, Bharath Chakravarthy, Sandra Springer, Sean D. Young   +4 more
openaire   +4 more sources

Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder

, 2021
Background: The COVID-19 pandemic significantly altered treatment delivery for opioid treatment programs (OTPs) dispensing medications for opioid use disorder (MOUD).
Ball, EL, Becker, SJ, Garner, BR, Hartzler, B, Jacka, BP , Janssen, T, Yap, KR, Yermash, J   +7 more
core   +1 more source

Opioid Use Disorder Treatment Discontinuation Among Postpartum Women in Western North Carolina [PDF]

, 2022
Opioid use disorder (OUD) is a widespread issue that has developed into an epidemic over the last several decades. It significantly affects thousands of pregnant women in the United States, leading to detrimental health outcomes for both mother and ...
Mohamed Raffi, Benazir Asifa
core   +2 more sources

Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community

Addiction Science & Clinical Practice, 2022
Background Medication treatment for opioid use disorder (OUD) (MOUD; buprenorphine and methadone) reduces opioid use and overdose. Discontinuation of MOUD can quickly lead to relapse, overdose and death.
Breanne E. Biondi, Brent Vander Wyk, Esther F. Schlossberg, Albert Shaw, Sandra A. Springer   +4 more
doaj   +1 more source

Implementing a Novel Statewide Network to Support Emergency Department-initiated Buprenorphine Treatment [PDF]

, 2022
Introduction: Medications for opioid use disorder (MOUD), including buprenorphine, represent an evidence-based treatment that supports long-term recovery and reduces risk of overdose death.
Burnett, Susan J., Clemency, Brian M., Hoopsick, Rachel A., Kahn, Linda S., Lynch, Joshua J.   +4 more
core   +1 more source

Optimizing Return and Secure Disposal of Prescription Opioids to Reduce the Diversion to Secondary Users and Black Market [PDF]

arXiv, 2022
Opioid Use Disorder (OUD) has reached an epidemic level in the US. Diversion of unused prescription opioids to secondary users and black market significantly contributes to the abuse and misuse of these highly addictive drugs, leading to the increased risk of OUD and accidental opioid overdose within communities.
arxiv  

A conceptual framework for how structural changes in emerging acute substance use service models can reduce stigma of medications for opioid use disorder

Frontiers in Psychiatry, 2023
Stigma toward people taking medication for opioid use disorder (MOUD) is prevalent, harmful to the health and well-being of this population, and impedes MOUD treatment resource provision, help-seeking, and engagement in care.
Timothy D. Becker, Timothy D. Becker, Evan L. Eschliman, Ashish P. Thakrar, Lawrence H. Yang, Lawrence H. Yang   +5 more
doaj   +1 more source

Improving Surveillance of Hepatitis C Infections Among Patients Receiving Medication Treatment for Opioid Use Disorder [PDF]

, 2020
Background: Despite harm reduction efforts, Hepatitis C virus (HCV) infections among individuals with opioid use disorder tripled between 2010 and 2015 in the US.
Bray, Jacqueline
core   +1 more source

Machine-learning Repurposing of DrugBank Compounds for Opioid Use Disorder [PDF]

arXiv, 2023
Opioid use disorder (OUD) is a chronic and relapsing condition that involves the continued and compulsive use of opioids despite harmful consequences. The development of medications with improved efficacy and safety profiles for OUD treatment is urgently needed.
arxiv  

Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder

Drug and Alcohol Dependence Reports, 2022
Introduction: Psychosocial support is recommended in conjunction with medication for opioid use disorder (MOUD), although optimal “dose,” modality, and timing of participation is not established.
Kathryn Hefner, Tse-Hwei Choo, Dikla Shmueli-Blumberg, Martina Pavlicova, Jacquie King, Marc Fishman, Matisyahu Shulman, Aimee Campbell, Miranda Greiner, Jennifer Scodes, Sarah Meyers-Ohki, Patricia Novo, Edward Nunes, John Rotrosen   +13 more
doaj